MiR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1

Cancer Letters

Volumn 362, Issue 2, 2015, Pages 183-191

  Fan, Song ^a   Chen, Wei Xiong ^a   Lv, Xiao Bin ^a   Tang, Qiong Lan ^a   Sun, Li Juan ^a   Liu, Bo Du ^a   Zhong, Jiang Long ^a   Lin, Zhao Yu ^a   Wang, You Yuan ^a   Li, Qun Xing ^a   Yu, Xin ^a   Zhang, Han Qing ^a   Li, Yi Lin ^b   Wen, Bin ^c   Zhang, Zhang ^d   Chen, Wei Liang ^a   Li, Jin Song ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Xaverian Brothers High School   (United States)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Cisplatin sensitivity; FIS1; MiR 483 5p; Mitochondrial fission; Tongue squamous cell carcinoma

Indexed keywords

CISPLATIN; MICRORNA; MICRORNA 483 5P; MITOCHONDRIAL FISSION 1 PROTEIN; MITOCHONDRIAL PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; FIS1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MIRN483 MICRORNA, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURGERY; CELL FUSION; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; FIS1 GENE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOCHONDRIAL FISSION; MITOCHONDRION; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TONGUE CARCINOMA; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CARCINOMA, SQUAMOUS CELL; DRUG EFFECTS; DRUG SCREENING; GENETIC TRANSFECTION; GENETICS; HEAD AND NECK NEOPLASMS; METABOLISM; MITOCHONDRIAL DYNAMICS; NUDE MOUSE; TONGUE NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CISPLATIN; HEAD AND NECK NEOPLASMS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PROTEINS; TONGUE NEOPLASMS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84928204096     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.03.045     Document Type: Article

References (33)

1. Suen D.F., Norris K.L., Youle R.J. Mitochondrial dynamics and apoptosis. Genes Dev 2008, 22:1577-1590.
2. Mishra P., Chan D.C. Mitochondrial dynamics and inheritance during cell division, development and disease. Nat. Rev. Mol. Cell Biol 2014, 15:634-646.
3. Brooks C., Wei Q., Cho S.G., Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J. Clin. Invest 2009, 119:1275-1285.
4. Galluzzi L., Senovilla L., Vitale I., Michels J., Martins I., Kepp O., et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012, 31:1869-1883.
5. Zhong L.P., Zhang C.P., Ren G.X., Guo W., William W.N., Sun J., et al. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J. Clin. Oncol 2013, 31:744-751.
6. Gibson M.K., Li Y., Murphy B., Hussain M.H., DeConti R.C., Ensley J., Forastiere A.A. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J. Clin. Oncol 2005, 23:3562-3567. Eastern Cooperative Oncology Group.
7. Kartalou M., Essigmann J.M. Mechanisms of resistance to cisplatin. Mutat. Res 2001, 478:23-43.
8. Qian W., Wang J., Van Houten B. The role of dynamin-related protein 1 in cancer growth: a promising therapeutic target?. Expert Opin. Ther. Targets 2013, 17:997-1001.
9. Lee Y.J., Jeong S.Y., Karbowski M., Smith C.L., Youle R.J. Roles of the mammalian mitochondrial fission and fusion mediators FIS1, DRP1, and Opa1 in apoptosis. Mol. Biol. Cell 2004, 15:5001-5011.
10. Palmer C.S., Osellame L.D., Laine D., Koutsopoulos O.S., Frazier A.E., Ryan M.T. MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep 2011, 12:565-573.
11. Suzuki M., Jeong S.Y., Karbowski M., Youle R.J., Tjandra N. The solution structure of human mitochondria fission protein FIS1 reveals a novel TPR-like helix bundle. J. Mol. Biol 2003, 334:445-458.
12. Sun L., Yao Y., Liu B., Lin Z., Lin L., Yang M., et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 2012, 31:432-445.
13. Kotowski U., Heiduschka G., Brunner M., Erovic B.M., Martinek H., Thurnher D. Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines. Oncol. Lett 2012, 3:1326-1330.
14. Wang J., Guan X., Guo F., Zhou J., Chang A., Sun B., et al. miR-30e reciprocally regulates the differentiation of adipocytes and osteoblasts by directly targeting low-density lipoprotein receptor-related protein 6. Cell Death Dis 2013, 4:e845.
15. Wang J.X., Jiao J.Q., Li Q., Long B., Wang K., Liu J.P., et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med 2011, 17:71-78.
16. Tanaka A., Youle R.J. A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis. Mol. Cell 2008, 29:409-4s
17. Li J., Huang H., Sun L., Yang M., Pan C., Chen W., et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin. Cancer Res 2009, 15:3998-4008.
18. Brooks C., Cho S.G., Wang C.Y., Yang T., Dong Z. Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis. Am. J. Physiol. Cell Physiol 2011, 300:C447-C455.
19. Farrand L., Kim J.Y., Im-Aram A., Suh J.Y., Lee H.J., Tsang B.K. An improved quantitative approach for the assessment of mitochondrial fragmentation in chemoresistant ovarian cancer cells. PLoS ONE 2013, 8:e74008.
20. Tamura Y., Itoh K., Sesaki H. SnapShot: mitochondrial dynamics. Cell 2011, 145:1158. 1158.e1.
21. McBride H.M., Neuspiel M., Wasiak S. Mitochondria: more than just a powerhouse. Curr. Biol 2006, 16:R551-R560.
22. Cipolat S., Rudka T., Hartmann D., Costa V., Serneels L., Craessaerts K., et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 2006, 126:163-175.
23. Sanchis D., Mayorga M., Ballester M., Comella J.X. Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytes. Cell Death Differ 2003, 10:977-986.
24. Tait S.W., Parsons M.J., Llambi F., Bouchier-Hayes L., Connell S., Muñoz-Pinedo C., et al. Resistance to caspase independent cell death requires persistence of intact mitochondria. Dev. Cell 2010, 18:802-813.
25. Westermann B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol 2010, 11:872-884.
26. Sheridan C., Delivani P., Cullen S.P., Martin S.J. Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome c release. Mol. Cell 2008, 31:570-585.
27. Drayton R.M. The role of microRNA in the response to cisplatin treatment. Biochem. Soc. Trans 2012, 40:821-825.
28. Ru P., Steele R., Hsueh E.C., Ray R.B. Anti-miR-203 upregulates SOCS3 expression in breast cancer cells and enhances cisplatin chemosensitivity. Genes Cancer 2011, 2:720-727.
29. Weeraratne S.D., Amani V., Neiss A., Teider N., Scott D.K., Pomeroy S.L., et al. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro-Oncol 2011, 13:165-175.
30. Bian H.B., Pan X., Yang J.S., Wang Z.X., De W. Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549). J. Exp. Clin. Cancer Res 2011, 30:20.
31. Rieswijk L., Lizarraga D., Brauers K.J., Kleinjans J.C., van Delft J.H. Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes, HepG2 cells and mouse embryonic stem cells shows conservation of regulating transcription factor networks. Mutagenesis 2014, 29:17-26.
32. St Germain C., Niknejad N., Ma L., Garbuio K., Hai T., Dimitroulakos J. Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3. Neoplasia 2010, 12:527-538.
33. Sood S., Srinivasan R. Alterations in gene promoter methylation and transcript expression induced by cisplatin in comparison to 5-azacytidine in HeLa and SiHa cervical cancer cell lines. Mol. Cell. Biochem 2015, 10.1007/s11010-015-2377-3.